GSTM1 and kidney disorder: Individuals with kidney disease retain the ability to generate EPO, and desidustat, categorized as an oral HIF-PHI, triggers the production of endogenous EPO, maintaining levels within or close to the physiological range and resulting in an elevation of Hb levels.